YMBA YM Bio. Com Shs

RNS Number:5654D
YM BioSciences Inc.
25 May 2006


YM BioSciences Inc. (the "Company")

The Company announces that 5,675,287 common shares have been issued as partial
vendor consideration in conjunction with the acquistion of Eximias
Pharmaceutical Corporation.  Application has been made for these shares to be
admitted to AIM.




                      This information is provided by RNS
            The company news service from the London Stock Exchange

END
IOEIIFIDEEIEFIR

YM Bio. Com Shs (LSE:YMBA)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024

YM Bio. Com Shs (LSE:YMBA)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024